Metropolis plans to enter capital marketDecember 13, 2018
Metropolis Healthcare Ltd, one of the leading diagnostics companies in India, has filed an offer document with the SEBI, proposing an Initial Public Offering (IPO) of its equity shares.
The Equity Shares offered through the Red Herring Prospectus are proposed to be listed on BSE and NSE.
The company’s IPO comprises up to 15.3 mln equity shares, consisting of an Offer for Sale of up to 5 mln shares by promoter Dr. Sushil Kanubhai Shah and up to 10.3 mln equity shares by investor CA Lotus Investments. The offer includes a reservation of up to 3 lakh equity shares for subscription by eligible employees.
The Book Running Lead Managers (BRLMs) are JM Financial Limited, Credit Suisse Securities (India) Private Limited, Goldman Sachs (India) Securities Private Limited, HDFC
Bank Limited and Kotak Mahindra Capital Company Limited.
Metropolis conducts operations through a laboratory and service network which covers 173 cities in India. During the financial year 2018, it conducted approximately 16 million tests from approximately 7.7 million patient visits, as per company data.